Found this one from the Gillies Mcindo Research Institute in New Zealand -
"The GMRI is currently conducting Phase I clinical trials on our new cancer treatment on patients with glioblastoma and malignant melanoma."
You can access more information on their website -
https://gmri.org.nz/cms/
Our clinical trial programme is testing the GMRI’s novel treatment approach by targeting cancer stem cells, the proposed origin of cancer. We are currently running two trials, focusing on patients with glioblastoma and patients with advanced malignant melanoma who have failed conventional treatment. The glioblastoma clinical trial is well underway and the early results are promising.
- Forums
- ASX - By Stock
- 6.2c then 7.6c then blue sky
Found this one from the Gillies Mcindo Research Institute in New...
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $8.229M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $73.58K | 18.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 16801257 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7789761 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7300000 | 0.004 |
31 | 36704631 | 0.003 |
18 | 31870001 | 0.002 |
13 | 51251998 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7789761 | 11 |
0.006 | 8669918 | 10 |
0.007 | 1525381 | 3 |
0.008 | 665910 | 2 |
0.010 | 275230 | 2 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online